glp-1 options for type 2 diabetes and obesity 2025 Agonists Market Report 2025-2033, By Product, Molecule, Geo GLP-1 Market Size, Share |

Knop, F.K

P., et al

Summary of GLP-1 vision loss concerns and industry impact Robbie Williams claims GLP-1 weight loss drugs are harming his vision Research links liraglutide and semaglutide to rare optic nerve damage No proven causal link yet but concerns may deter some GLP-1 users Food and beverage brands face uncertainty as GLP-1 adoption trends shift Natural GLP-1 alternatives gain traction amid fears of drug side effects GLP-1 weight loss drugs have known side effects

What HPLC purity is acceptable

FDA Approval and Indications Both medications are FDA-approved, but the approval depends on the brand and indication

Different timelines include: 612 months: To kickstart weight loss and develop healthier routines